Longitudinal Free-Water Changes in Dementia with Lewy Bodies

Shannon Y Chiu1,2, Robin Chen3, Wei-En Wang3

  • 1Department of Neurology, University of Florida, Gainesville, Florida, USA.

Abstract

Insights

Free-water (FW) imaging revealed increased neurodegeneration in dementia with Lewy bodies (DLB) over time. These microstructural changes correlated with cognitive and motor decline, supporting dMRI as a tool for tracking DLB progression.

Area of Science:

  • Neuroimaging
  • Neurodegenerative Diseases
  • Biomarkers

Background:

  • Diffusion-weighted magnetic resonance imaging (dMRI) assesses in vivo tissue microstructure.
  • Previous dMRI studies in dementia with Lewy bodies (DLB) have shown inconsistent findings.

Purpose of the Study:

  • To utilize free-water (FW) imaging to evaluate DLB progression.
  • To correlate FW changes with clinical decline in DLB patients.

Main Methods:

  • Baseline and follow-up MRIs were acquired at 12 and 24 months for 27 individuals with DLB or mild cognitive impairment with Lewy bodies (MCI-LB).
  • Free-water (FW) was analyzed using the Mayo Clinic Adult Lifespan Template.
  • 20 cognitively unimpaired individuals from the Alzheimer's Disease Neuroimaging Initiative were included for longitudinal comparison.

Main Results:

  • Significant FW increases were observed in multiple brain regions, including the insula, amygdala, and cingulate cortex, at 12 and 24 months compared to baseline.
  • More widespread microstructural changes, particularly in areas related to visuospatial processing, motor, and cholinergic functions, were noted at 24 months.
  • FW changes were significantly associated with longitudinal worsening of cognitive (Montreal Cognitive Assessment - MoCA) and motor (Movement Disorder Society-Unified Parkinson's Disease Rating Scale - MDS-UPDRS) scores.

Conclusions:

  • Free-water (FW) accumulation in gray and white matter regions indicates neurodegenerative pathology and disease progression in DLB.
  • The observed association between FW changes and clinical decline highlights its potential as a marker for DLB progression.
  • dMRI, specifically FW imaging, shows promise as a tool for monitoring disease progression in DLB.